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Introduction
Germ cell tumours are a heterogeneous group of neoplasms 
arising from primordial germ cells. Teratomas are the most 
common type of germ cell tumours. Struma ovarii are a rare type 
of monodermal teratoma containing more than 50% thyroid 
tissue, and account for approximately 2–3% of teratomas.1
Struma ovarii typically occur between the ages of 30 and 50 
years.1 As with germ cell tumours, women usually present with 
abdominal distension due to the mass and ascites, abdominal 
pain due to torsion, and occasionally with symptoms due to 
hormonal production.2 Ascites occurs in approximately 10% of 
women, and in some cases this can be combined with a pleural 
effusion (modified Meigs syndrome).3 Peritoneal implants can 
also occur from benign lesions, called peritoneal strumosis.4  
Roughly 5–8% of patients with struma ovarii have clinical 
signs of hyperthyroidism.5 As benign struma ovarii contain 
normal thyroid tissue, they have a high uptake of iodine and 
can secrete thyroid hormones.6 A small percentage of benign 
struma undergo malignant transformation. Often malignant 
struma do not produce thyroid hormone, however, when 
hyperthyroidism exists in malignant struma 83% of patients have 
distant metastases.6 Hyperthyroidism can be life threatening if 
not diagnosed preoperatively as thyrotoxic crisis can occur.7 
These patients should be treated with a beta blocker and attain a 
euthyroid state with the use of a thionamide for 4–6 weeks prior 
to surgery.4
There is no typical ultrasound feature of struma, although it could 
be suspected if there is a large solid component on ultrasound.8 
Tumour markers are of little clinical value. The cancer antigen 
(CA)-125 may be raised in some patients, especially those with 
ascites, but is not reliable in women of reproductive age.1 If the 
patient has functioning thyroid tissue in the tumour and a normal 
thyroid gland, then thyroid-stimulating hormone, thyroxine, 
triiodothyronine and thyroglobulin levels can be used to assist 
in diagnosis. Thyroglobulin can be used for follow-up as a marker 
of response to treatment, especially in cases of malignancy and 
metastases.9 The diagnosis of struma ovarii is most often made 
postoperatively on histology.
Method
The Tygerberg National Health Laboratory Service database 
was searched for diagnoses of struma ovarii from 2012–2014 by 
International Classification of Diseases, Revision 10 code. Four 
women were found who had had surgery for ovarian masses 
which were diagnosed as struma ovarii postoperatively. Their 
case notes were retrospectively reviewed.  
Results
The four patients had a wide variation in age (20–52 years) 
and different presenting complaints, and there was a differing 
approach to surgery for all of them based on the findings of the 
preoperative investigations.  
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Case 1
A 20-year-old nulliparous woman presented with a one week 
history of nausea, epigastric tenderness and abdominal 
distension. She had regular menses and was not on any hormonal 
contraception. On examination, her thyroid was not enlarged and 
her pulse rate was 78 beats per minute (bpm). She had a central 
mobile mass arising from the pelvis of approximately 25 cm, with 
no ascites clinically. The ultrasound revealed a complex mass 
with solid and cystic components (102 x 112 x 64 mm) posterior 
to the uterus and moderate ascites. Evidence of metastases was 
not seen on further imaging. Investigations showed a lactate 
dehydrogenase of 595, alpha-fetoprotein of 2.2, beta human 
chorionic gonadotropin of < 1 and CA-125 of 486 kU/l.
These results raised the suspicion of primitive germ cell 
malignancy. Three weeks after presentation, the patient 
underwent a laparotomy and left adnexectomy. At surgery, a 
smooth-walled, 25 x 15 cm left ovarian mass was seen. There was 
no capsular invasion or sign of peritoneal spread. The uterus and 
right ovary looked normal.
Histology
Macroscopically, the ovarian tumour comprised multiloculated 
cysts containing gelatinous brown, mucinous material. On 
microscopy, the ovarian mass showed predominantly thyroid 
follicles, some filled with colloid. There were no malignant 
features. The immunohistochemical stains were positive for 
thyroglobulin and thyroid transcription factor-1 (TTF-1). Thus, a 
diagnosis of struma ovarii was made.
Case 2
A 52-year-old postmenopausal woman presented with a four-
month history of increasing abdominal distension, shortness of 
breath and loss of appetite. She had no other known medical 
illnesses. She had undergone five vaginal deliveries, and her only 
previous surgical procedure was a sterilisation. On examination, 
her thyroid was not enlarged and her pulse rate was 60 bpm. 
Her abdomen was distended, a mass of approximately 10 cm 
could be felt, and ascites was demonstrated with a fluid thrill. 
An ultrasound and computed tomography scan confirmed 
a complex solid and cystic mass arising from the right ovary 
measuring 11 x 12 cm. Massive ascites were also present with 
left-sided pleural effusion; both cytologically negative for 
malignancy. Tumour markers showed a CA-125 of 1 115 kU/l. 
The patient was suspected of having ovarian carcinoma. Thus, 
she underwent a staging laparotomy with a total abdominal 
hysterectomy, bilateral salpingo-oophorectomy and omental 
biopsy. At surgery, the mass was removed with the capsule 
intact. There was no sign of peritoneal spread.
Histology
Sections from the ovarian mass showed histological features of 
pure struma ovarii without any associated dermoid components. 
The struma was composed of thyroid tissue with a predominantly 
microfollicular pattern, and large cysts filled with colloid.
Malignant features of papillary thyroid carcinoma were absent. 
Thyroglobulin and TTF-1 confirmed a thyroid origin.
Case 3
A 50-year-old woman presented with post-coital bleeding. 
An ultrasound was performed, and an incidental finding of 
a 9 x 8 cm left adnexal cyst with a large solid component was 
seen. There were no ascites on ultrasound. The patient had no 
known medical conditions. She had been amenorhoiec for 
five months and was thought to be perimenopausal. She had 
had two previous Caesarean sections, and there was no other 
surgical history. There was no family history of breast or ovarian 
cancer. On examination, her thyroid and pulse rate was normal. 
Her abdomen was not distended and there were no palpable 
masses. The investigation showed a CA-125 of 16 kU/l. The 
patient had a low Risk of Malignancy Index score. However, the 
ultrasound features were concerning. Thus, she underwent a 
total abdominal hysterectomy, bilateral salpingo-oophorectomy 
and omental biopsy.
Histology
The right ovary showed histological features in keeping with 
struma ovarii. The cyst wall contained benign thyroid tissue, with 
no evidence of mature or immature tissue elements. The uterus 
contained multiple small fibroids, with no evidence of any other 
pathology.
Case 4
A 47-year-old premenopausal woman presented to the surgeon 
with symptoms of cholelithiasis. On ultrasound scan, there was 
an incidental finding of a dermoid cyst measuring 7 x 5 cm, 
comprising solid and cystic components. The patient had had 
two previous Caesarean sections and was a type 2 diabetic on 
insulin and oral treatment. The investigation showed a CA-125 
of 13 kU/l. There were no concerns about malignancy. Therefore, 
the surgery was planned as a laparoscopic procedure. The 
patient underwent a laparoscopic cholecystectomy and right 
adnexectomy, and had an uncomplicated postoperative course.  
Histology
A multiloculated cyst, primarly made up of thyroid follicles 
containing colloid, was seen on microscopy. There were also foci 
of mature adipose tissue, squamous epithelium and respiratory 
epithelium. A diagnosis of struma ovarii with associated dermoid 
tissue was made.
Discussion
As the diagnosis of struma ovarii is usually made postoperatively, 
most women undergo a staging laparotomy, total abdominal 
hysterectomy, bilateral salpingo-oophorectomy and omen-
tectomy, with the removal of macroscopic disease, where 
possible, as for any other suspected ovarian malignancy. Our 
patients had surgery which varied in extent from a laparoscopic 
adnexectomy to a full-staging laparotomy, depending on the pre-
surgical suspicion of malignancy and their menopausal status. 
A unilateral salpingo-oophorectomy is adequate in women who 
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wish to retain fertility, and this would be the definitive treatment 
in benign disease. All our patients had benign disease.
The definition of struma ovarii is a mature teratoma 
comprising thyroid tissue exclusively or predominantly. The 
histopathological appearance is characteristic, resembling 
mature thyroid tissue composed of variably sized thyroid 
follicles filled with colloid. Some areas are cellular, containing 
microfollicles, and others show a more trabecular to solid growth 
pattern. Immunhistochemically, these cells stain for thyroglobin 
and TTF-1, which confirms the thyroidal nature of the tissue.7
Malignant transformation occurs in less than 5% of struma, 
and the histological criteria are the same as those for thyroid 
malignancies.10 Thyroid-type carcinoma originating in struma 
ovarii needs to be differentiated from thyroid carcinoma with 
metastases to the ovaries.7 If a primary ovarian malignancy is 
present, then adjuvant treatment with a total thyroidectomy and 
radioactive  iodine (I-131) therapy has been shown to decrease 
recurrence and mortality rates.8 Serum thyroglobulin can be 
used as a marker for the recurrence of disease.10 Women should 
be advised not to fall pregnant for six months following I-131 
treatment as there is an increased risk of miscarriage. The side-
effects of 131-I therapy also include transient amenorrhoea and 
early menopause.6
It is difficult to distinguish between struma ovarii and ovarian 
carcinoma preoperatively as the symptoms, clinical presentation 
and image on ultrasound are often similar. These patients 
with benign disease often have more extensive surgery than 
necessary, resulting in a large abdominal scar, a longer hospital 
stay and a more lengthy recovery. The removal of both ovaries 
may induce or worsen menopausal symptoms, and leads to an 
increased risk of all-cause mortality and coronary heart disease. 
An ovarian cyst with a large solid component on ultrasound 
may raise suspicions of struma ovarii. Nurliza Binti Md et al. 
recommend using magnetic resonance imaging and serum 
thyroglobulin to preoperatively diagnose struma, and then 
proceed to a laparoscopic procedure.11 If struma ovarii is 
suspected, thyroid functions should be tested. This test does 
not only aid in diagnosis, but also avoids thyroid crisis during 
surgery. I-131 scintigraphy can be used to confirm the presence 
of ovarian thyroid tissue and locate metastatic disease.3 
Although struma ovarii are rare, a high index of suspicion and 
relevant preoperative testing may facilitate in diagnosis, allow 
appropriate surgery to be performed, and spare women from 
unnecessary morbidity.
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